The payer community is confronted every day with new tests that are being developed without an understanding of which should be reimbursed because they will improve the healthcare of their insured population and make the cost of that healthcare more effective and more efficient, reducing that overall cost.

Identify the Actionable Information to Produce the Next Step in Treatment

To make that happen, they need to understand where the tests are converted into actionable items, and not just tests that provide more information. Adding more information to the mix doesn’t solve the question of what do you do next.

SMI helps payer organizations identify the actionable information that is necessary to produce the next step in the treatment, whether the treatment is for a patient or something that can be applied to designing new drugs or diagnostics